Palleon’s first CSO explains how they (and she) got here; Enterprise taps Roche and Novartis vet David Morris as CMO

Li Peng, Palleon

Click on the image to see the full-sized version

For a decade, Li Peng built antibodies at the MedImmune labs outside DC: A bispecific Amgen is now testing in GI cancer, an Il-5 for certain kinds of asthma, another that impacts natural killer cells near tumors. It was a sensible approach. The…

Click to view original post